Insider Trading History of Nodelman Oleg

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Nodelman Oleg since 2013. This trader's CIK number is 1454385. At the time of last reporting, Nodelman Oleg was the Officer of Zymeworks Inc.. (stock ticker symbol ZYME). Also see all insider trading activities at Zymeworks Inc..

Note that in the past NODELMAN OLEG also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Kindred Biosciences, Inc. (KIN) by Nodelman Oleg

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 KIN 232,244 $2,360,988 0 $0 0 $0
2013 KIN 400,000 $2,800,000 0 $0 0 $0

Yearly summary of insider trading at Zymeworks Inc. (ZYME) by Nodelman Oleg

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ZYME 2,163,747 $26,071,681 0 $0 0 $0

Yearly summary of insider trading at Anaptysbio, Inc (ANAB) by Nodelman Oleg

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ANAB 668,237 $14,453,966 668,237 $14,453,966 0 $0
2021 ANAB 368,800 $8,627,663 0 $0 0 $0

Yearly summary of insider trading at Genvec Inc (GNVC) by Nodelman Oleg

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 GNVC 146,413 $366,072 0 $0 0 $0


Insider trading activities at 4 companies by Nodelman Oleg:

1. Kindred Biosciences, Inc. (KIN)

2. Zymeworks Inc. (ZYME)

3. Anaptysbio, Inc (ANAB)

4. Genvec Inc (GNVC)

Table 1. Insider trading of Kindred Biosciences, Inc. (KIN) by Nodelman Oleg

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-09-29 KIN Buy 100,000 9.56 956,000
2014-08-27 KIN Buy 22,000 10.70 235,422
2014-08-28 KIN Buy 25,000 10.98 274,500
2014-08-25 KIN Buy 50,900 10.49 534,042
2014-08-26 KIN Buy 34,344 10.51 361,024
2013-12-12 KIN Buy 400,000 7.00 2,800,000

Table 2. Insider trading of Zymeworks Inc. (ZYME) by Nodelman Oleg

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-19 ZYME Buy 5,919 11.78 69,737
2025-05-15 ZYME Buy 49,502 11.43 565,857
2025-04-16 ZYME Buy 73,953 11.16 825,611
2025-04-17 ZYME Buy 54,760 11.52 630,835
2025-04-04 ZYME Buy 196,438 11.17 2,193,819
2025-04-03 ZYME Buy 120,770 11.84 1,430,158
2025-04-01 ZYME Buy 48,658 11.60 564,627
2025-04-02 ZYME Buy 74,360 11.85 881,017
2025-03-31 ZYME Buy 4,397 11.75 51,660
2025-03-26 ZYME Buy 43,848 12.24 536,874
2025-03-25 ZYME Buy 53,501 12.90 690,430
2025-03-20 ZYME Buy 73,476 12.93 949,897
2025-03-21 ZYME Buy 31,033 12.78 396,508
2025-03-24 ZYME Buy 22,689 13.08 296,840
2025-03-19 ZYME Buy 58,306 12.64 737,221
2025-03-18 ZYME Buy 113,880 12.65 1,440,809
2025-03-17 ZYME Buy 56,277 12.23 688,492
2025-03-13 ZYME Buy 468,356 12.48 5,847,424
2025-03-11 ZYME Buy 320,690 11.49 3,686,010
2025-03-12 ZYME Buy 292,934 12.25 3,587,855

Table 3. Insider trading of Anaptysbio, Inc (ANAB) by Nodelman Oleg

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-05 ANAB Buy 668,237 21.63 14,453,966
2022-05-05 ANAB Sale 668,237 21.63 14,453,966
2021-04-30 ANAB Buy 35,700 23.16 826,812
2021-05-03 ANAB Buy 20,800 23.31 484,868
2021-05-04 ANAB Buy 165,000 23.25 3,835,755
2021-04-27 ANAB Buy 33,800 23.82 805,082
2021-04-26 ANAB Buy 13,900 23.80 330,861
2021-04-23 ANAB Buy 99,600 23.54 2,344,285

Table 4. Insider trading of Genvec Inc (GNVC) by Nodelman Oleg

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-05-23 GNVC Buy 4,600 2.19 10,097
2014-05-22 GNVC Buy 10,500 2.13 22,365
2014-05-27 GNVC Buy 9,040 2.39 21,623
2014-03-26 GNVC Buy 23,543 2.31 54,502
2014-03-27 GNVC Buy 51,215 2.49 127,627
2014-03-28 GNVC Buy 47,515 2.73 129,858

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nodelman Oleg (Officer of Zymeworks Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.